| C Scot Mccusker, LPN | |
|
344 E 100 S Ste 301, Salt Lake City, UT 84111-1727 | |
| (801) 428-4257 | |
| Not Available |
| Full Name | C Scot Mccusker |
|---|---|
| Gender | Male |
| Speciality | Licensed Practical Nurse |
| Location | 344 E 100 S Ste 301, Salt Lake City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134870405 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 12476182-3101 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| C Scot Mccusker, LPN 344 E 100 S Ste 301, Salt Lake City, UT 84111-1727 Ph: (801) 428-4257 | C Scot Mccusker, LPN 344 E 100 S Ste 301, Salt Lake City, UT 84111-1727 Ph: (801) 428-4257 |
News Archive
Forty percent of U.S. adults intend to change their holiday plans due to the risk of being exposed to the H1N1 flu virus, according to a nationwide survey commissioned by JohnsonDiversey, a global leader in the commercial cleaning and sanitizing industry.
The ongoing COVID-19 pandemic has baffled researchers with its propensity to cause symptoms of largely unpredictable severity in the affected individuals. An exciting new study reports on the potential predictive value of platelet size in this situation. COVID-19 patients with severe disease often develop clots in vital organs, which leads to further complications. It is known that platelet size is a good indicator of activation.
A new study by researchers from Harvard T.H. Chan School of Public Health and colleagues describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.
The World Health Organization (WHO) has suspended its efforts to contain the outbreak of the deadly Marburg virus in Angola, in the northern province of Uige, after staff in their mobile surveillance vehicles have been attacked.
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,883,872 entitled, Construction of Highly Efficient Cellulase Compositions for Enzymatic Hydrolysis of Cellulose, by the United States Patent and Trademark Office ("USPTO").
› Verified 2 days ago
Ms. Crystal Renee Cox, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Salt Lake City, UT 84121 Phone: 801-263-7100 | |
Danielle Watson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Salt Lake City, UT 84121 Phone: 801-263-7100 | |
Lorie Lee Pierce, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Salt Lake City, UT 84121 Phone: 801-263-7100 | |
Holly Jackson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2040 Murray Holladay Rd Ste 205, Salt Lake City, UT 84117 Phone: 801-274-0299 | |
Amber Gregg, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 344 E 100 S, Suite 301, Salt Lake City, UT 84111 Phone: 801-322-4257 | |
Melissa Nelson, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Salt Lake City, UT 84121 Phone: 801-263-7100 |